Fast Five Quiz: Recurrent/Metastatic Cervical Cancer

Sarah Ackroyd, MD, MPH


May 31, 2023

Cervical cancer is the fourth most common malignancy in women worldwide and is the second most common cancer in developing countries where the majority of cases occur. An estimated 604,000 new cases of cervical cancer are diagnosed, and an estimated 342,000 deaths are reported worldwide.

The incidence of cervical cancer has declined owing to screening with a pap smear test and diagnostic efforts directed toward early identification of high-risk human papilloma virus (HPV) infections through the use of HPV testing and pap smears. Further, owing to the development of HPV vaccines, cervical cancer is considered a preventable disease.

Despite advances in treatment, prognosis remains poor in patients with recurrent or metastatic disease. Median overall survival has been reported to range from approximately 13 to 17 months with standard treatment regimens. One recent study reported an improvement in 2-year survival rate from 42% to 53% with the addition of immunotherapy.

How familiar are you with recurrent or metastatic cervical cancer? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.